IntroductionNonsecretory myeloma (NSM) is defined by the absence of serum or urinary (or both) monoclonal immunoglobulins in patients who otherwise manifest features typically found in multiple myeloma (MM). 1,2 This condition, which occurs in about 1% to 5% of patients with MM, results either from the inability of malignant plasma cells to synthesize immunoglobulin (ie, nonproducer) or, more commonly, the failure of such components to be exported from the cells (ie, nonsecretor). In the latter case, it has been assumed that the protein undergoes intracellular proteolysis due to a structural defect in the immunoglobulin and, as a consequence, is not excreted. However, there is only limited information regarding the molecular factors that might account for this phenomenon. [3][4][5][6][7] We now report our finding that the plasma cells of an individual with NSM indeed synthesized aberrant monoclonal light chains that resulted from a somatic mutation in the gene encoding the constant (C L ) region of the molecule. Our studies provide the first conclusive evidence that an abnormality in this portion of the light chain may be implicated in the pathogenesis of this disorder.
Study design Protein analysesSerum IgG, IgA, and IgM proteins were quantitated with the Synchron LX20 Clinical System (Beckman Coulter, Fullerton, CA) and the concentration of free and light chains determined by enzyme-linked immunosorbent assay (ELISA), using our highly specific monoclonal antibodies (mAbs), 8 as well as by nephelometry (Free Lite, The Binding Site, Birmingham, United Kingdom) with polyclonal reagents. 9 For detection of monotypic immunoglobulins, serum was diluted 1:10 and subjected to immunofixation electrophoresis using the Paragon system (Beckman, Norcross, GA), according to the procedure specified by the manufacturer. Undiluted samples also were examined in similar fashion, as were unconcentrated urine specimens and 24-hour collections that had been dialyzed extensively against distilled water, lyophilized, and reconstituted to a protein concentration of 100 mg/mL. 10
ImmunocytochemistryBone marrow plasma cells were isolated and immunostained with our murine mAbs specific for human light-chain variable region (V L ) subgroups 11 and for total (heavy chain-bound) and free (unbound) and polypeptides, 8 as well as with mouse antihuman plasma cell (Dako, Carpinteria, CA) and rabbit antihuman ␥, ␣, , and ␦ heavy-chain antisera (Biosource, Camarillo, CA).
RNA preparation and RT-PCR amplificationTotal RNA was extracted from plasma cells with the PURESCRIPT RNA isolation kit (Gentra, Minneapolis, MN) and transcribed with both oligo (dT) 15 and random primers, using reverse transcriptase (RT; Promega, Madison, WI) in a single reaction. First-strand DNA was amplified by forward and reverse primers specifying the first and last 7 amino acid residues of a prototypic 1 light chain. 12 The polymerase chain reaction (PCR) products were cloned using the perfectly blunt cloning kit with the pSTBlue-1 vector (Novagen, Madison, WI) and the co...